A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Ossium Health, Inc.
Apollo Therapeutics Ltd
ARCE Therapeutics, Inc.
ARCE Therapeutics, Inc.
Incyte Corporation